ARVO Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dahlin, D.
Right arrow Articles by Chastain, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dahlin, D.
Right arrow Articles by Chastain, J.
Invest Ophthalmol Vis Sci 2002;43: E-Abstract 4109.
© 2002 ARVO

Bimatoprost Hydrolysis to 17-phenyl PGF2{alpha} by Rabbit and Monkey Ocular Tissues, in vivo

DC Dahlin, MV W Bergamini, MA Curtis, TR Dean, CC Kiehlbauch and JE Chastain

1 Alcon Research Ltd Fort Worth TX

Commercial Relationships:   D.C. Dahlin, Alcon Research, Ltd. E; M.V.W. Bergamini, Alcon Research, Ltd. E; M.A. Curtis, Alcon Research, Ltd. E; T.R. Dean, Alcon Research, Ltd. E; C.C. Kiehlbauch, Alcon Research, Ltd. E; J.E. Chastain, Alcon Research, Ltd. E.
Grant Identification: Supported by Alcon Research, Ltd.

Abstract

Purpose: Bimatoprost is the ethyl amide of the potent prostaglandin FP agonist, 17-phenyl PGF2{alpha}. The in vivo hydrolysis of bimatoprost by ocular tissues was investigated in rabbits and monkeys following single topical ocular administration of bimatoprost.
Methods: Male Dutch-Belted rabbits and Cynomolgus monkeys were administered a single 30-µL dose of a 0.03% bimatoprost ophthalmic solution (LUMIGAN®) into both eyes. Blood was sampled and animals euthanized at 0.5, 1, 2 and 4 hr post-dose, at which times ocular tissues (aqueous humor, iris-ciliary body and cornea) were collected. An LC/MS/MS method was used to measure bimatoprost and 17-phenyl PGF2{alpha}.
Results: Hydrolysis of bimatoprost to 17-phenyl PGF2{alpha} occurred in both rabbit and monkey ocular tissues, in vivo. A species difference was observed with hydrolysis being substantially greater in rabbits than monkeys. In rabbits, virtually complete hydrolysis was observed, while in the monkey, levels of bimatoprost exceeded those for 17-phenyl PGF2{alpha}. Maximal mean concentrations (Cmax) of bimatoprost and 17-phenyl PGF2{alpha} in rabbits were, respectively, 5.07 ± 0.79 ng/g and 22.5 ± 2.2 ng/g in iris-ciliary body, and 0.939 ± 0.542 ng/mL and 42.3 ± 7.0 ng/mL in aqueous humor. Cmax in monkey aqueous humor was 10.0 ± 6.5 ng/mL for bimatoprost and 1.95 ± 1.39 ng/mL for 17-phenyl PGF2{alpha}, while Cmax levels in the cornea were 161 ± 91 ng/g and 25.5 ± 21.2 ng/g, respectively. Plasma concentrations of bimatoprost were quantifiable in the monkey, but not the rabbit, while 17-phenyl PGF2{alpha} levels were nonquantifiable in both species (quantitation limit: 0.1-0.2 ng/mL for bimatoprost and 0.5-1 ng/mL for 17-phenyl PGF2{alpha}.
Conclusion: Bimatoprost was hydrolyzed to the potent FP agonist, 17-phenyl PGF2{alpha} in rabbit and monkey ocular tissues, in vivo. Hydrolysis was greater in rabbit than in monkey eyes but both produced pharmacologically relevant concentrations of 17-phenyl PGF2{alpha}.

Keywords: 541 receptors: pharmacology/physiology • 577 second messengers: pharmacology/physiology • 581 signal transduction: pharmacology/physiology

© 2002, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. For permission to reproduce any part of this abstract, contact the ARVO Office at arvo{at}arvo.org.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH